{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:13:29Z","timestamp":1786374809732,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.2459\/jcm.0b013e328316912f","type":"journal-article","created":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T08:36:53Z","timestamp":1283330213000},"page":"1274-1278","source":"Crossref","is-referenced-by-count":9,"title":["Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on serum matrix metalloproteinase-13 and tissue inhibitor matrix metalloproteinase-1 levels as a sign of plaque stabilization"],"prefix":"10.2459","volume":"9","author":[{"given":"Cihan","family":"Cevik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Otahbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chokesuwattanaskul","family":"Warangkana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Meyerrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210207","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.97.24.2433","article-title":"Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization","volume":"97","author":"Aikawa","year":"1998","journal-title":"Circulation"},{"key":"R2-13-20210207","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1161\/01.CIR.99.19.2503","article-title":"Evidence for increased collagenolysis by interstitial collagenases-1 and \u20133 in vulnerable human atheromatous plaques","volume":"99","author":"Sukhova","year":"1999","journal-title":"Circulation"},{"key":"R3-13-20210207","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/hc4101.097419","article-title":"Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling","volume":"104","author":"Herman","year":"2001","journal-title":"Circulation"},{"key":"R4-13-20210207","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.amjcard.2003.08.061","article-title":"Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome","volume":"92","author":"Inoue","year":"2003","journal-title":"Am J Cardiol"},{"key":"R5-13-20210207","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejim.2007.01.007","article-title":"The role of matrix metalloproteinases in acute coronary syndromes","volume":"18","author":"Dabek","year":"2007","journal-title":"Eur J Intern Med"},{"key":"R6-13-20210207","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.18.11.1671","article-title":"HMG-CoA Reductase inhibitors reduce MMP-9 secretion by macrophages","volume":"18","author":"Bellosta","year":"1998","journal-title":"Arterioscler Thromb Vasc Bio"},{"key":"R7-13-20210207","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9149(01)01616-2","article-title":"Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases","volume":"88","author":"Kalela","year":"2001","journal-title":"Am J Car"},{"key":"R8-13-20210207","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1161\/CIRCULATIONAHA.105.562041","article-title":"Matrix metalloproteinase-13\/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques","volume":"112","author":"Deguchi","year":"2005","journal-title":"Circulation"},{"key":"R9-13-20210207","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.amjcard.2006.07.047","article-title":"Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus","volume":"98","author":"Hernandez","year":"2006","journal-title":"Am J Cardiol"},{"key":"R10-13-20210207","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"R11-13-20210207","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"R12-13-20210207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2006.08.012","article-title":"Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina","volume":"376","author":"Li","year":"2007","journal-title":"Clin Chim Acta"},{"key":"R13-13-20210207","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archinte.163.11.1323","article-title":"The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study","volume":"163","author":"van der Meer","year":"2003","journal-title":"Arch Intern Med"},{"key":"R14-13-20210207","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2362.2007.01919.x","article-title":"Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction","volume":"38","author":"Suzuki","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"R15-13-20210207","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/STROKEAHA.107.492470","article-title":"Intravenous rosuvastatin for acute stroke treatment: an animal study","volume":"39","author":"Prinz","year":"2008","journal-title":"Stroke"},{"key":"R16-13-20210207","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2362.2006.01598.x","article-title":"Effects of simvastatin withdrawal on serum matrix metalloproteinases in hypercholesterolaemic patients","volume":"36","author":"Huang","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"R17-13-20210207","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/01.CIR.0000145118.55201.15","article-title":"There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients","volume":"110","author":"McGowan","year":"2004","journal-title":"Circulation"},{"key":"R18-13-20210207","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.amjcard.2003.09.031","article-title":"Treating to New Targets (TNT) Study: does lowering low density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?","volume":"93","author":"Waters","year":"2003","journal-title":"Am J Cardiol"},{"key":"R19-13-20210207","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","article-title":"Withdrawal of statins increases event rates in patients with acute coronary syndromes","volume":"105","author":"Heeschen","year":"2002","journal-title":"Circulation"},{"key":"R20-13-20210207","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1161\/01.CIR.0000050552.32300.93","article-title":"Withdrawal of statins in patients with acute coronary syndromes","volume":"107","author":"Heeschen","year":"2003","journal-title":"Circulation"},{"key":"R21-13-20210207","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina: Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators.","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"R22-13-20210207","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-200812000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:18:17Z","timestamp":1786371497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-200812000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e328316912f","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}